Three separate decisions, seven decades apart, add up to the same result: reinvention stopped being available to almost everyone in America. A federal database ended distance as an escape. A Supreme Court doctrine ended "I served my time" as an argument. Silicon Valley built a private exception to both -- and Florida shows just how far a democracy can walk back a fix even when 65% of voters demand it.

HoloMD's Dr. Holo doesn't provide therapy or crisis care -- it surfaces patterns between visits for trained staff to review and a treating provider to act on, billed through a specific Medicare Remote Therapeutic Monitoring code family (effective Jan 2022, with cognitive-behavioral monitoring added Jan 2023). The real contrast with unsupervised consumer AI chatbots isn't whether AI is present -- it's who stays accountable for what it notices.

Municipal budget cuts after 2008 and the pandemic left real gaps in youth sports funding, and private equity moved in — buying rinks, apparel makers, tournament operators, and the streaming rights to a kid's own game. One senator says he was told his own son's hockey team would lose standing points if he livestreamed a game. He's now co-sponsoring a bill to force private equity out entirely.

Physical AI just split into three real, currently active layers: a platform to simulate and train a robot in a digital twin before it's real, a standard for controlling real hardware once it's deployed, and the physical chip the robot actually computes on in the field. All three launched or expanded within the same several months of 2025 and 2026. NVIDIA already holds two of the three layers in the same live deployment.

The eyewear industry's real structure is a vertical-integration story most buyers never see: one company designs, manufactures, licenses, and retails a huge share of the world's glasses. A separate, smaller story sits underneath it — virtual try-on technology, attempted three times over seventeen years, twice too early and once, finally, on time. That gap between a good idea and a workable one is exactly what a real diligence process is built to catch.

The Sherman Antitrust Act was ruled powerless against a 98% sugar monopoly and unanimously effective against Eugene Debs' union, months apart, in 1895. That asymmetry -- concentrated capital getting a real fight, organized labor getting broken by default -- runs in an unbroken line to Google's 2025 remedies ruling on one side and an NLRB left without a quorum on the other.

Theranos, WeWork, and Juicero collapsed on the same pattern: a claim that didn't survive contact with reality. What actually explains younger generations' distrust of Silicon Valley isn't any single failure -- it's that WeWork's founder walked away with $1.7 billion and got funded again anyway.

An ordinary person circumventing DRM to watch a movie they legally bought has zero fair-use defense available under the DMCA. A company training AI on the same kind of copyrighted material gets an actual, fact-specific fair-use inquiry — one that can go either way, and did, twice, within months.

"Buy" and "purchase" on a digital storefront have never meant what they mean everywhere else — the transaction is a revocable license, and companies have said so explicitly in court.

Park City, Utah has two ski resorts that both call themselves the biggest thing to happen to skiing there in decades. Neither one is owned by anyone who lives there.

Detroit filed the largest municipal bankruptcy in American history in July 2013, carrying roughly $18 billion in debt. It exited in eighteen months -- one of the fastest major municipal bankruptcies ever resolved -- and the city's bankruptcy case only finished closing out in federal court this year, 2026. In between, one businessman spent more on downtown real estate than most cities' entire annual budgets. The recovery is real. It is not evenly distributed.

Judith Faulkner built Epic Systems into a company holding 56.9 percent of America's hospital-bed market by refusing every outside investor for 47 years. Nine miles away, University Research Park's Forward BIOLABS was built on the opposite premise -- that early biotech startups survive by sharing lab benches, not guarding them. Both drew on the same University of Wisconsin-Madison talent pipeline. As of late 2025, one of the two bets is now facing a state attorney general's antitrust lawsuit, a federal antitrust suit, and an FTC investigation, all at once.